¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multiple abscess"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic abscess
    ÃâÇ÷°í¸§Áý, ÃâÇ÷³ó¾ç
  • lacrimal abscess
    ´«¹°ÁÖ¸Ó´Ï°í¸§Áý, ´©³¶³ó¾ç
  • migrating abscess
    À̵¿°í¸§Áý, À̵¿³ó¾ç
  • miliary abscess
    Á¼½Ò°í¸§Áý, ¼Ó¸³³ó¾ç
  • milk abscess
    Á¥»ù°í¸§Áý, À¯¼±³ó¾ç
  • mural abscess
    ¹èº®°í¸§Áý, º¹º®³ó¾ç
  • metastatic abscess
    ÀüÀÌ°í¸§Áý, ÀüÀ̳ó¾ç
  • orbital abscess
    ´«È®°í¸§Áý, ¾È¿Í³ó¾ç
  • phlegmonous abscess
    ¿¬Á¶Á÷³ó¾ç, ¿¬Á¶Á÷°í¸§Áý
  • pancreatic abscess
    ÀÌÀÚ°í¸§Áý, ÃéÀå³ó¾ç
  • psoas abscess
    Ç㸮±Ù°í¸§Áý, ¿ä±Ù³ó¾ç
  • parametritic abscess
    ÀÚ±ÃÁÖÀ§Á¶Á÷°í¸§Áý, ÀÚ±ÃÁÖÀ§Á¶Á÷³ó¾ç
  • paranephric abscess
    ÄáÆÏÁÖÀ§°í¸§Áý, ½ÅÀåÁÖÀ§³ó¾ç
  • palatal abscess
    ÀÔõÀå°í¸§Áý, ±¸°³³ó¾ç
  • pelvic abscess
    °ñ¹Ý°í¸§Áý, °ñ¹Ý³ó¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • gingival abscess
    ÀÕ¸ö°í¸§Áý, Ä¡Àº³ó¾ç
  • hemorrhagic abscess
    ÃâÇ÷°í¸§Áý, ÃâÇ÷³ó¾ç
  • lacrimal abscess
    ´«¹°ÁÖ¸Ó´Ï°í¸§Áý, ´©³¶³ó¾ç
  • metastatic abscess
    ÀüÀÌ°í¸§Áý, ÀüÀ̳ó¾ç
  • migrating abscess
    À¯ÁÖ°í¸§Áý, À¯ÁÖ³ó¾ç
  • miliary abscess
    Á¼½Ò°í¸§Áý, ¼Ó¸³³ó¾ç
  • milk abscess
    Á¥»ù°í¸§Áý, Á¥»ù³ó¾ç
  • mural abscess
    ¹èº®°í¸§Áý, º¹º®³ó¾ç
  • orbital abscess
    ´«È®°í¸§Áý, ¾È¿Í³ó¾ç
  • ossifluent abscess
    (¢¡osteomyelitis) °ñ¼ö¿°, »À¼ÓÁú¿°
  • palatal abscess
    ÀÔõÀå°í¸§Áý, ±¸°³³ó¾ç
  • parametritic abscess
    ÀÚ±ÃÁÖÀ§Á¶Á÷°í¸§Áý, ÀÚ±ÃÁÖÀ§Á¶Á÷³ó¾ç
  • paranephric abscess
    ÄáÆÏÁÖº¯°í¸§Áý, ½ÅÁÖº¯³ó¾ç
  • pelvic abscess
    °ñ¹Ý°í¸§Áý, °ñ¹Ý³ó¾ç
  • perianal abscess
    Ç×¹®ÁÖÀ§°í¸§Áý, Ç×¹®ÁÖÀ§³ó¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • iliac abscess
    Àå°ñ(ºÎ)³ó¾ç.
  • iliacal abscess
    Àå°ñ¿Í³ó¾ç.
  • iliacal abscess
    Àå°ñ¿Í ³ó¾ç.
  • iliopsoas abscess
    Àå¿ä±Ù³ó¾ç.
  • phlegmonous abscess
    ºÀ¼Ò¿°¼º ³ó¾ç(Üðáµæúàõ ÒÛåË), °áÇÕÁ¶Á÷¿°¼º ³ó¾ç(Ì¿ùêðÚòÄæúàõ ÒÛåË)
  • postcecal abscess
    ¸ÍÀåÈijó¾ç(¡­³ó¾ç).
  • postcecal abscess
    ¸ÍÀåÈijó¾ç(Øîíóý­ÒÛåË)
  • prostatic abscess
    Àü¸³¼±³ó¾ç(¡­ÒÛåË).
  • prostatic abscess
    Àü¸³¼±³ó¾ç(îñí¡àÍÒÛåË)
  • psoas abscess
    ¿ä±Ù³ó¾ç(¿ä±Ù³ó¾ç).
  • psoas abscess
    ¼Ò¾Æ½º³ó¾ç
  • psoas abscess
    ¿ä±Ù³ó¾ç
  • pulmonary abscess
    Æó³ó¾ç(øËÒÛåË).
  • rectal abscess
    Á÷Àå³ó¾ç(Á÷Àå³ó¾ç).
  • rectal abscess
    Á÷Àå³ó¾ç(òÁíóÒÛåË)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • multiple evanescent white dot syndrome
    ´Ù¹ß¼º¼Ò½Ç¼º¹é¹ÝÁõÈıº
  • multiple excitaiton
    ´ÙÁß ¿©±â
  • multiple excitation
    ¹Ýº¹ÈïºÐ(ÚãÜÖýéÝÇ).
  • multiple exostoses =diaphyseal aclasis
    ´Ù¹ß¼º ¿Ü°ñÁõ(¡­ èâÍéñø)
  • multiple exostosis =diaphyseal aclasis
    ´Ù¹ß¼º ¿Ü°ñÁõ(ÒýÛ¡àõèâÍéñø), ´Ù¹ß¼º °ñ¿¬°ñÁ¾(ÒýÛ¡àõÍéæãÍéðþ).
  • multiple fetation
    ´Ù¼öÀÓ½Å(Òýâ¦ìôãã).
  • multiple fibrofolliculoma
    ´Ù¹ß¼º¼¶À¯¸ð³¶Á¾
  • multiple fibrofolliculomas
    ´Ù¹ß¼º ¼¶À¯¸ð³¶Á¾
  • multiple fibroma
    ´Ù¹ß¼º ¼¶À¯Á¾.
  • multiple field irradiation
    ´ÙÁ¶»ç¿µ¿ªÄ¡·á
  • multiple fission
    ´Ù¼öºÐ¿­(Òýâ¦ÝÂæñ).
  • multiple fraction per day, MFD
    ÀÏÀÏ´ÙºÐÇÒÁ¶»ç¹ý
  • multiple fracture
    ´Ù¹ß¼º °ñÀý(ÒýÛ¡àõÍéï¹).
  • multiple genes
    ´ÙÀ¯ÀüÀÚ.
  • multiple genes
    º¹¼öÀ¯ÀüÀÚ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CPMS chronic progressive multiple sclerosis
CSMB Center for the Study of Multiple Births
FAMMM familial atypical multiple mole-melanoma [syndrome]
FMEN familial multiple endocrine neoplasia
FMFD V familial multiple coagulation factor deficiency V
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MDR Multiple Drug Resistance
MEA Multiple Endocrine Adenomatosis
MEN Multiple Endocrine Neoplasia
MEN I Multiple Endocrine Neoplasia
MEN 1 Multiple Endocrine Neoplasia Type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic alveolar abscess
    ¸¸¼º Ä¡Á¶ ³ó¾ç
    Ä¡±Ù´Ü Ä¡Á¶°ñÀÌ Àå±â°£ µ¿¾È ³·Àº Á¤µµ·Î °¨¿°µÈ °Í.
  • circumtonsillar abscess
    Æíµµ ÁÖÀ§ ³ó¾ç
  • consecutive abscess
    ¼Ó¹ß¼º ³ó¾ç
  • dry abscess
    °Ç¼º ³ó¾ç
  • epidural abscess
    °æ¸·¿Ü ³ó¾ç
    µ¿ÀǾî=extradural abscess.
  • fixation abscess
    °íÁ¤ ³ó¾ç
  • iliopsoas abscess
    Àå¿ä±Ù ³ó¾ç
  • lingual abscess
    ¼³ ³ó¾ç
  • liver abscess
    °£ ³ó¾ç
  • migrating abscess
    À¯ÁÖ ³ó¾ç
  • odontogenic peritonsillar abscess
    Ä¡¼º Æíµµ ÁÖÀ§ ³ó¾ç
  • ossifluent abscess
    °ñÈ­ ³ó¾ç, °ñÈ­¼º ³ó¾ç
  • palatal abscess
    ±¸°³ ³ó¾ç
    »ó¾ÇÄ¡ÀÇ ±Ù÷ ÁÖÀ§ ¶Ç´Â Ä¡±Ù¸·ÀÇ ³ó¾çÀ¸·Î¼­ ±¸°³ ÂÊÀ¸·Î È®´ëµÈ °Í.
  • parametric abscess
    Àڱà ÁÖÀ§ Á¶Á÷ ³ó¾ç
  • paranephric abscess
    ½Å ÁÖÀ§ ³ó¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
hamartoma syndrome, multiple A hereditary disease characterised by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.
(12 Dec 1998)
pregnancy, multiple The condition of bearing two or more foetuses simultaneously.
(12 Dec 1998)
hereditary multiple exostoses A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
hereditary multiple trichoepithelioma <tumour> Multiple small benign nodules, occurring mostly on the skin of the face, derived from basal cells of hair follicles enclosing small keratin cysts; frequent autosomal dominant inheritance.
Synonym: acanthoma adenoides cysticum, Brooke's tumour, epithelioma adenoides cysticum, hereditary multiple trichoepithelioma.
Origin: tricho-+ epithelioma
(05 Mar 2000)
sclerosis, multiple The National Multiple Sclerosis Society says of ms that it is a disease that randomly attacks your central nervous system, wearing away the control you have over your body. Symptoms may range from numbness to paralysis and blindness. The progress, severity and specific symptoms cannot be foreseen. You never know when attacks will occur, how long they will last, or how severe they will be. most people are diagnosed with ms between the ages of 20 and 40. In medical terms, ms involves demyelinization of the white matter sometimes extending into the gray matter. Demyelinization is loss of myelin, the coating of nerve fibres composed of lipids (fats) and protein that serves as insulation and permits efficient nerve fibre conduction. The white matter is the part of the brain which contains myelinated nerve fibres and appears white, whereas the gray matter is the cortex of the brain which contains nerve cell bodies and appears gray. When myelin is damaged in ms, nerve fibre conduction is faulty or absent. Impaired bodily functions or altered sensations associated with those demyelinated nerve fibres give rise to the symptoms of ms. Recent research (1998) has also identified nerve cell death as part of the nervous system injury in ms.
(12 Dec 1998)
psychotherapy, multiple The use of more than one therapist at one time in individual or group psychotherapy.
(12 Dec 1998)
neoplasms, multiple primary Two or more abnormal growths of tissue occurring simultaneously. The neoplasms are histologically different and may be found in the same or different sites.
(12 Dec 1998)
drug resistance, multiple Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, p-glycoprotein.
(12 Dec 1998)
exostoses, multiple hereditary Hereditary disorder transmitted by an autosomal dominant gene and characterised by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.
(12 Dec 1998)
familial multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
law of multiple proportions The relative weights in which two substances form a chemical union singly with a third are the same as, or simple multiples of, those in which they unite with each other; a corollary of the law of definite proportions.
Synonym: law of multiple proportions.
(05 Mar 2000)
lipomatosis, multiple symmetrical Multiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck.
(12 Dec 1998)
abdominal abscess <surgery> A localised pus-forming (suppurative) bacterial infection that occurs within the abdominal cavity as the result of a perforated viscus or post operative complication. Treatment requires either percutaneous or open surgical drainage.
(27 Sep 1997)
abscess <microbiology, surgery> A localised collection of pus caused by suppuration buried in tissues, organs or confined spaces. Usually due to an infective process.
Origin: L. Abscessus, from ab = away, cedere = to go
(18 Nov 1997)
abscess, peritonsillar A persistent collection of pus behind the tonsil.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á